Human medicines European public assessment report (EPAR): NovoRapid, insulin aspart, Diabetes Mellitus, Date of authorisation: 07/09/1999, Revision: 30, Status: Authorised

2019 ◽  
Author(s):  
Keyword(s):  
Diabetes Mellitus ◽  
Insulin Aspart ◽  
Assessment Report ◽  
European Public ◽  
European Public Assessment Report
Sign in / Sign up

Export Citation Format

Share Document